Answers are grounded in this paper and cite their sources.
resulted in phenotypic and functional activation of intratumoral macrophages with M1 phenotypes and a reciprocal reduction in M2-like suppressive activities. Together, these findings provide evidence that nonvirulent tumor-targeting bacteria releasing multiple TLR ligands can be used as cancer immunotherapeutics.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: